Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides.
We have isolated two Chinese hamster ovary cell lines, designated ADR-4 and ADR-5, which exhibit hypersensitivity to intercalating agents and epipodophyllotoxins. These drugs are thought to exert their cytotoxicity via an interaction with the enzyme topoisomerase II. However, there is no apparent change in the level or catalytic activity of topoisomerase II in the mutant cells. Drug sensitivity does not appear to be due to increased drug transport because accumulation of radiolabeled actinomycin D is similar in mutant and wild-type cells. Both mutant cell lines show enhanced resistance to hydrogen peroxide and to organic peroxides. ADR-4 cells show a degree of temperature sensitivity. ADR-5 cells show mild sensitivity to UV irradiation. Neither cell line shows significant sensitivity to mono- or bifunctional alkylating agents, ionizing radiation, or bleomycin. Cell fusion studies indicate that the phenotype of each mutant cell line is recessive and that the mutants represent two different genetic complementation groups. These studies also indicate that ADR-4 and ADR-5 Adriamycin-sensitive mutant, ADR-1. These results indicate that sensitivity to topoisomerase II inhibitors can result from abnormalities in several genes. These drug-sensitive mutants may be useful for studying the mechanisms of cell killing by topoisomerase II inhibitors, free radicals, and heat.
Davies
S M
SM
Department of Clinical Oncology, University of Newcastle upon Tyne, Medical School, United Kingdom.
Davies
S L
SL
Harris
A L
AL
Hickson
I D
ID
D000677:Amsacrine / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D006224:Cricetinae; D004250:DNA Topoisomerases, Type II / Q000032:analysis; D003609:Dactinomycin / Q000378:metabolism*; D004317:Doxorubicin / Q000378:metabolism*; D004351:Drug Resistance; D005047:Etoposide / Q000378:metabolism; D005260:Female; D008942:Mitoxantrone / Q000378:metabolism; D009154:Mutation; D010053:Ovary / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D013713:Teniposide / Q000378:metabolism; D059005:Topoisomerase II Inhibitors
D059005:Topoisomerase II Inhibitors; D000677:Amsacrine; D003609:Dactinomycin; D005047:Etoposide; D004317:Doxorubicin; D013713:Teniposide; D008942:Mitoxantrone; D004250:DNA Topoisomerases, Type II